|
|
|

|
| AIDS
Updates |
|
|
DRUG
INTERACTIONS IN HIV THERAPY
A Clinician's Guide |
|
|
DRUGS THAT SHOULD
NOT BE USED WITH ANTIRETROVIRALS
|
a) Protease inhibitors
|
ü= may be used; x = not to be used
|
|
Drug
Category
|
Indinavir |
Ritonavir** |
Saquinavir |
Nelfinavir
|
Amprenavir
|
Lopinavir +
Ritonavir
|
| Ca++
channel blocker |
ü |
xBepridil |
ü |
ü |
xBepridil |
(none) |
| Cardiac |
ü |
xAmiodarone,
flecainide,
propafenone,
quinidine |
ü |
ü |
ü |
Flecainide
propafenone |
Lipid
Lowering
Agents |
xSimvastatin,
lovastatin |
xSimvastatin,
lovastatin |
xSimvastatin,
lovastatin |
xSimvastatin,
lovastatin |
xSimvastatin,
lovastatin |
xSimvastatin,
lovastatin |
Anti-
Mycobacterial |
xRifampin |
ü |
xRifampin
rifabutin |
xRifampin |
xRifampin |
xRifampin |
| Antihistamine |
xAstemizole,
terfenadine |
xAstemizole,
terfenadine |
xAstemizole,
terfenadine |
xAstemizole,
terfenadine |
xAstemizole,
terfenadine |
xAstemizole,
terfenadine |
Gastrointestinal
Drugs |
XCisapride*** |
XCisapride*** |
XCisapride*** |
XCisapride*** |
XCisapride*** |
XCisapride*** |
| Neuroleptic |
ü |
XClozapine,
pimozide |
ü |
ü |
ü |
xPimozide |
| Psychotropic |
xMidazolam,
triazolam |
xMidazolam,
triazolam |
xMidazolam,
triazolam |
xMidazolam,
triazolam |
xMidazolam,
triazolam |
xMidazolam,
triazolam |
Ergot
Alkaloids
(vasoconstrictor) |
xDihydroergo
-tamine
(D.H.E.45),
ergotamine*
(various
forms) |
xDihydroergo
-tamine
(D.H.E.45),
ergotamine*
(various
forms) |
xDihydroergo
-tamine
(D.H.E.45),
ergotamine*
(various
forms) |
xDihydroergo
-tamine
(D.H.E.45),
ergotamine*
(various
forms) |
xDihydroergo
-tamine
(D.H.E.45),
ergotamine*
(various
forms) |
xDihydroergo
-tamine
(D.H.E.45),
ergotamine*
(various
forms) |
|
** Some of the contraindicated drugs
listed are based on theoretical considerations. Thus, drugs
with low
therapeutic indices yet with suspected major metabolic contribution
from cytochrome P450
3A, CYP2D6, or unknown pathways are included in this table.
Actual interactions may or may
not occur in patients.
* This is likely to be a class
effect.
*** Cisapride has been withdrawn from the market
by the US FDA.
|
|
|
b) Non-nucleoside reverse
transcriptase inhibitors
|
ü= may be used; x = not to be used
|
|
Drug
Category
|
Nevirapine |
Delavirdine |
Efavirenz
|
| Ca++
channel blocker |
ü |
ü |
ü |
| Cardiac |
ü |
ü |
ü |
Lipid
Lowering
Agents
|
ü |
xSimvastatin,
lovastatin
|
ü |
| Anti-Mycobacterial |
Insufficient
data |
xRifampin,
rifabutin |
ü |
| Antihistamine |
ü |
xAstemizole,
terfenadine
|
xAstemizole,
terfenadine |
Gastrointestinal
Drugs |
ü |
XCisapride
H2 blockers,
Proton pump
inhibitors
|
XCisapride* |
Neuroleptic
Psychotropic |
ü
ü |
ü
xMidazolam,
triazolam
|
ü
xMidazolam,
triazolam
|
Ergot
Alkaloids
(Vasoconstrictor) |
ü |
xDihydroergotamine
(D.H.E.45),
ergotamine*
(various forms)
|
xDihydroergotamine
(D.H.E.45),
ergotamine*
(various forms) |
|
* This is likely a class effect
Suggested Alternatives
Simvastatin, lovastatin: atorvastatin, pravastatin, fluvastatin,
cerivastatin (alternatives should be used with caution).
Rifabutin: clarithromycin, azithromycin (MAI prophylaxis);
clarithromycin, ethambutol (MAI treatment).
Astemizole, terfenadine: loratidine, fexofenadine, cetirizine
Midazolam, triazolam: temazepam, lorazepam
|
|
|
| |